Landmark review backs puberty blockers for Australian youth
A long-awaited review says they should be available for eligible under-18s, with options guided by clinical assessment and shared decision-making.
https://www1.racgp.org.au/newsgp/clinical/landmark-review-backs-puberty-blockers-for-austral



